Neprilysin gene transfer reduces human amyloid pathology in transgenic mice

J Neurosci. 2003 Mar 15;23(6):1992-6. doi: 10.1523/JNEUROSCI.23-06-01992.2003.

Abstract

The degenerative process of Alzheimer's disease is linked to a shift in the balance between amyloid-beta (Abeta) production, clearance, and degradation. Neprilysin has recently been implicated as a major extracellular Abeta degrading enzyme in the brain. However, there has been no direct demonstration that neprilysin antagonizes the deposition of amyloid-beta in vivo. To address this issue, a lentiviral vector expressing human neprilysin (Lenti-Nep) was tested in transgenic mouse models of amyloidosis. We show that unilateral intracerebral injection of Lenti-Nep reduced amyloid-beta deposits by half relative to the untreated side. Furthermore, Lenti-Nep ameliorated neurodegenerative alterations in the frontal cortex and hippocampus of these transgenic mice. These data further support a role for neprilysin in regulating cerebral amyloid deposition and suggest that gene transfer approaches might have potential for the development of alternative therapies for Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / genetics
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Protein Precursor / genetics
  • Amyloidosis / genetics*
  • Amyloidosis / therapy*
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Cell Line
  • Disease Models, Animal
  • Drug Administration Routes
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Frontal Lobe / pathology
  • Gene Transfer Techniques
  • Genes, Reporter
  • Genetic Therapy / methods*
  • Genetic Vectors / administration & dosage
  • Genetic Vectors / genetics
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Kidney / cytology
  • Kidney / metabolism
  • Lentivirus / genetics
  • Mice
  • Mice, Transgenic
  • Neprilysin / biosynthesis
  • Neprilysin / genetics*
  • Neprilysin / pharmacology*
  • Peptide Fragments / metabolism
  • Plaque, Amyloid / drug effects
  • Plaque, Amyloid / pathology
  • Stem Cells / metabolism
  • Treatment Outcome

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Neprilysin